CanSino Biologics Inc (CJH) — Capital Reinvestment Ratio
CanSino Biologics Inc (CJH) has a Capital Reinvestment Ratio of 0.35x as of December 2021, meaning it reinvests 0% of its operating cash flow (€806.73 Million) in capital expenditures (€284.07 Million). See CanSino Biologics Inc net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CanSino Biologics Inc Capital Reinvestment Ratio (2021–2025)
This chart tracks CanSino Biologics Inc's Capital Reinvestment Ratio across 2 annual periods. Check total reinvestment intensity of CanSino Biologics Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for CanSino Biologics Inc (2021–2025)
Year-by-year Capital Reinvestment Ratio for CanSino Biologics Inc from 2021 to 2025. For live market cap and broader valuation context, see how much is CanSino Biologics Inc worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.13x | €77.86 Million | €243.90 Million | ▲ +433.8% |
| 2021 | 0.59x | €2.05 Billion | €1.20 Billion | — |